15 organizations named this bill in their lobbying registration or in
40 reported meetings. Their own words are quoted.
-
Bristol Myers Squibb Canada
20 meetings · registered to lobby on it · latest Oct 7, 2026
“Bill C-64 (Pharmacare Act - 2024) Patented Medicine Prices Review Board (PMPRB) Reform Most Favored Nation National Pharmacare Drugs for Rare Diseases”
-
Novo Nordisk Canada Inc.
10 meetings · registered to lobby on it · latest Sep 18, 2026
“Bill C-64, the Pharmacare Act, with respect to definitional questions related to terms contained in Section 6.1, and concerns regarding the increased risk of drug shortages.”
-
Sandoz Canada Inc.
3 meetings · was registered on it · latest Nov 19, 2024
“Amend Bill C-64 to remove the risks and uncertainty that would undermine the stability and affordability of Canada's drug supply.”
-
Breakthrough T1D
2 meetings · registered to lobby on it · latest Jul 17, 2026
“Ensuring Bill C-64, the National Pharmacare Act, meets the needs of Canadians living with type 1 diabetes by having adequate insulin and diabetes devices coverage, while respecting…”
-
Canadian Labour Congress
2 meetings · was registered on it · latest Oct 16, 2024
“Bill C-64, Pharmacare Act Specifically provisions that deal with ensuring public, universal access to diabetes and contraceptive medications and devices.”
-
Arthritis Society Canada
2 meetings · was registered on it · latest Oct 8, 2024
“Discussion with government officials about national pharmacare (Bill C-64) and timely access to treatment for people living with arthritis.”
-
Canadian Life and Health Insurance Association
1 meeting · was registered on it · latest Feb 10, 2026
“Discussions relating to the implementation of the pharmacare act (Bill C-64).”
-
Eli Lilly Canada Inc.
registered to lobby on it · latest Aug 16, 2026
“C-64, An act respecting pharmacare - discussions around the structuring and implementation of a national pharmacare program.”
-
Manulife
was registered on it · latest Jan 10, 2025
“…the client to communicate with the Government of Canada surrounding policies related to Bill C-64 ( Pharmacare Act), and highlighting the impacts and consequences of implementation of the G20 inclusive framework on Base Erosion and Profit Sharing (BEPS) as it…”
-
Best Medicines Coalition
was registered on it · latest Sep 25, 2024
“Recommend the creation of a Patient Ombudsman, as part of Bill C-64 or separately.”
-
Best Medicines Coalition
was registered on it · latest Sep 25, 2024
“Recommend the creation of a Patient Ombudsman, as part of Bill C-64 or separately.”
-
Canadian Life and Health Insurance Association Inc.
was registered on it · latest Sep 17, 2024
“…health benefit plans to continue to do so even for those medications covered under Bill C-64.”
-
Arthritis Society Canada
was registered on it · latest Aug 22, 2024
“Discussion with government officials about national pharmacare (Bill C-64) and timely access to treatment for people living with arthritis.”
-
Arthritis Society Canada
was registered on it · latest May 22, 2024
“Discussion with government officials about national pharmacare (Bill C-64) and timely access to treatment for people living with arthritis.”
-
Arthritis Society Canada
was registered on it · latest May 21, 2024
“Discussion with government officials about national pharmacare (Bill C-64) and timely access to treatment for people living with arthritis.”
From the Commissioner of Lobbying. A bill is listed when the lobbyist's description makes clear it means this bill, not one with the same number from another Parliament.